作者: Leo E. Otterbein , Augustine M. K. Choi
DOI:
关键词:
摘要: The present invention relates to the use of carbon monoxide (CO) as a biomarker and therapeutic agent heart, lung, liver, spleen, brain, skin kidney diseases other conditions disease states including, for example, asthma, emphysema, bronchitis, adult respiratory distress syndrome, sepsis, cystic fibrosis, pneumonia, interstitial lung diseases, idiopathic pulmonary including primary hypertension, secondary cancers, larynx throat cancer, arthritis, wound healing, Parkinson's disease, Alzheimer's peripheral vascular thrombotic such embolism. CO may be used provide anti-inflammatory relief in patients suffering from oxidative stress especially sepsis septic shock. In addition, or reducing transplant reduce inhibit inflammation patients.